Clinical Trial Update: A Phase II Study of Parotid-gland Sparing IMRT in Patients With Midline Tumour of the Head and Neck

View source ↗

Summary

Phase II trial evaluating parotid-gland sparing IMRT for midline head and neck cancers. The study includes patients with oropharyngeal and hypopharyngeal squamo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopharyngeal Squamous Cell Carcinoma
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Royal Marsden NHS Foundation Trust | Conditions: Oropharyngeal Squamous Cell Cancer, Hypopharyngeal Squamous Cell Cancer | Status: COMPLETED